{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:07:32Z","timestamp":1790856452138,"version":"4.1.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The intestinal barrier is a complex structure that not only regulates the influx of luminal contents into the systemic circulation but is also involved in immune, microbial, and metabolic homeostasis. Evidence implicating disruption in intestinal barrier functions in the development of many systemic diseases, ranging from non-alcoholic steatohepatitis to autism, or systemic complications of intestinal disorders has increased rapidly in recent years, raising the possibility of the intestinal barrier as a potential target for therapeutic intervention to alter the course and mitigate the complications associated with these diseases. In addition to the disease process being associated with a breach in the intestinal barrier functions, patients with hematologic and oncologic diseases are particularly at high risks for the development of increased intestinal permeability, due to the frequent use of broad-spectrum antibiotics and chemoradiation. They also face a distinct challenge of being intermittently severely neutropenic due to treatment of the underlying conditions. In this review, we will discuss how hematologic and oncologic diseases are associated with disruption in the intestinal barrier and highlight the complications associated with an increase in the intestinal permeability. We will explore methods to modulate the complication. To provide a background for our discussion, we will first examine the structure and appraise the methods of evaluation of the intestinal barrier.<\/jats:p>","DOI":"10.1186\/s12967-023-04091-w","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T10:03:30Z","timestamp":1680257010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Intestinal barrier functions in hematologic and oncologic diseases"],"prefix":"10.1186","volume":"21","author":[{"given":"Elio","family":"Haroun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanth Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kassab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyendu","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-5989","authenticated-orcid":false,"given":"Seah H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"4091_CR1","doi-asserted-by":"publisher","first-page":"628157","DOI":"10.1155\/2015\/628157","volume":"2015","author":"A Michielan","year":"2015","unstructured":"Michielan A, D\u2019Inc\u00e0 R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm. 2015;2015:628157.","journal-title":"Mediators Inflamm"},{"key":"4091_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.dld.2004.01.013","volume":"36","author":"D Pizzuti","year":"2004","unstructured":"Pizzuti D, Bortolami M, Mazzon E, Buda A, Guariso G, D\u2019Odorico A, Chiarelli S, D\u2019Inc\u00e0 R, De Lazzari F, Martines D. Transcriptional downregulation of tight junction protein ZO-1 in active coeliac disease is reversed after a gluten-free diet. Dig Liver Dis. 2004;36:337\u201341.","journal-title":"Dig Liver Dis"},{"key":"4091_CR3","doi-asserted-by":"publisher","first-page":"8351","DOI":"10.3390\/ijms21218351","volume":"21","author":"J Plaza-D\u00edaz","year":"2020","unstructured":"Plaza-D\u00edaz J, Sol\u00eds-Urra P, Rodr\u00edguez-Rodr\u00edguez F, Olivares-Arancibia J, Navarro-Oliveros M, Abad\u00eda-Molina F, \u00c1lvarez-Mercado AI. The gut barrier, intestinal microbiota, and liver disease: molecular mechanisms and strategies to manage. Int J Mol Sci. 2020;21:8351.","journal-title":"Int J Mol Sci"},{"key":"4091_CR4","doi-asserted-by":"publisher","first-page":"107766","DOI":"10.1016\/j.jdiacomp.2020.107766","volume":"35","author":"JH Yuan","year":"2021","unstructured":"Yuan JH, Xie QS, Chen GC, Huang CL, Yu T, Chen QK, Li JY. Impaired intestinal barrier function in type 2 diabetic patients measured by serum LPS, Zonulin, and IFABP. J Diabetes Complicat. 2021;35:107766.","journal-title":"J Diabetes Complicat"},{"key":"4091_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13229-016-0110-z","volume":"7","author":"M Fiorentino","year":"2016","unstructured":"Fiorentino M, Sapone A, Senger S, Camhi SS, Kadzielski SM, Buie TM, Kelly DL, Cascella N, Fasano A. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism. 2016;7:49.","journal-title":"Mol Autism"},{"key":"4091_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","volume":"11","author":"M Vancamelbeke","year":"2017","unstructured":"Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 2017;11:821\u201334.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"4091_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrgastro.2013.35","volume":"10","author":"ME Johansson","year":"2013","unstructured":"Johansson ME, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol. 2013;10:352\u201361.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4091_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nri.2016.88","volume":"16","author":"ME Johansson","year":"2016","unstructured":"Johansson ME, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol. 2016;16:639\u201349.","journal-title":"Nat Rev Immunol"},{"key":"4091_CR9","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1007\/s00018-011-0822-3","volume":"68","author":"ME Johansson","year":"2011","unstructured":"Johansson ME, Ambort D, Pelaseyed T, Sch\u00fctte A, Gustafsson JK, Ermund A, Subramani DB, Holm\u00e9n-Larsson JM, Thomsson KA, Bergstr\u00f6m JH, van der Post S, Rodriguez-Pi\u00f1eiro AM, Sj\u00f6vall H, B\u00e4ckstr\u00f6m M, Hansson GC. Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci. 2011;68:3635\u201341.","journal-title":"Cell Mol Life Sci"},{"key":"4091_CR10","doi-asserted-by":"publisher","first-page":"e982426","DOI":"10.4161\/21688370.2014.982426","volume":"3","author":"S Cornick","year":"2015","unstructured":"Cornick S, Tawiah A, Chadee K. Roles and regulation of the mucus barrier in the gut. Tissue Barriers. 2015;3:e982426.","journal-title":"Tissue Barriers"},{"key":"4091_CR11","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1111\/j.1462-5822.2005.00595.x","volume":"7","author":"M Zareie","year":"2005","unstructured":"Zareie M, Riff J, Donato K, McKay DM, Perdue MH, Soderholm JD, Karmali M, Cohen MB, Hawkins J, Sherman PM. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. Cell Microbiol. 2005;7:1782\u201397.","journal-title":"Cell Microbiol"},{"key":"4091_CR12","doi-asserted-by":"publisher","first-page":"G559","DOI":"10.1152\/ajpgi.00066.2017","volume":"312","author":"JP Karl","year":"2017","unstructured":"Karl JP, Margolis LM, Madslien EH, Murphy NE, Castellani JW, Gundersen Y, Hoke AV, Levangie MW, Kumar R, Chakraborty N, Gautam A, Hammamieh R, Martini S, Montain SJ, Pasiakos SM. Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress. Am J Physiol Gastrointest Liver Physiol. 2017;312:G559\u201371.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4091_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jcmgh.2020.04.001","volume":"10","author":"L Zuo","year":"2020","unstructured":"Zuo L, Kuo WT, Turner JR. Tight junctions as targets and effectors of mucosal immune homeostasis. Cell Mol Gastroenterol Hepatol. 2020;10:327\u201340.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4091_CR14","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1091\/mbc.e12-09-0688","volume":"24","author":"MM Buschmann","year":"2013","unstructured":"Buschmann MM, Shen L, Rajapakse H, Raleigh DR, Wang Y, Wang Y, Lingaraju A, Zha J, Abbott E, McAuley EM, Breskin LA, Wu L, Anderson K, Turner JR, Weber CR. Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Mol Biol Cell. 2013;24:3056\u201368.","journal-title":"Mol Biol Cell"},{"key":"4091_CR15","doi-asserted-by":"publisher","first-page":"C1378","DOI":"10.1152\/ajpcell.1997.273.4.C1378","volume":"273","author":"JR Turner","year":"1997","unstructured":"Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, Mrsny RJ, Madara JL. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol. 1997;273:C1378\u201385.","journal-title":"Am J Physiol"},{"key":"4091_CR16","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.1074\/jbc.M109.064808","volume":"285","author":"CR Weber","year":"2010","unstructured":"Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, Turner JR. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem. 2010;285:12037\u201346.","journal-title":"J Biol Chem"},{"key":"4091_CR17","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1091\/mbc.e09-01-0080","volume":"20","author":"SM Krug","year":"2009","unstructured":"Krug SM, Amasheh S, Richter JF, Milatz S, G\u00fcnzel D, Westphal JK, Huber O, Schulzke JD, Fromm M. Tricellulin forms a barrier to macromolecules in tricellular tight junctions without affecting ion permeability. Mol Biol Cell. 2009;20:3713\u201324.","journal-title":"Mol Biol Cell"},{"key":"4091_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1053\/j.gastro.2008.10.081","volume":"136","author":"L Su","year":"2009","unstructured":"Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, Abraham C, Turner JR. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterol. 2009;136:551\u201363.","journal-title":"Gastroenterol"},{"key":"4091_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.200902153","volume":"189","author":"AM Marchiando","year":"2010","unstructured":"Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR 2nd, Raleigh DR, Guan Y, Watson AJ, Montrose MH, Turner JR. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol. 2010;189:111\u201326.","journal-title":"J Cell Biol"},{"key":"4091_CR20","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1096\/fj.02-0121fje","volume":"16","author":"AS Fanning","year":"2002","unstructured":"Fanning AS, Ma TY, Anderson JM. Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB J. 2002;16:1835\u20137.","journal-title":"FASEB J"},{"key":"4091_CR21","doi-asserted-by":"publisher","first-page":"8237","DOI":"10.1073\/pnas.0908869107","volume":"107","author":"D Yu","year":"2010","unstructured":"Yu D, Marchiando AM, Weber CR, Raleigh DR, Wang Y, Shen L, Turner JR. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci USA. 2010;107:8237\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4091_CR22","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1091\/mbc.e09-04-0320","volume":"20","author":"CM Van Itallie","year":"2009","unstructured":"Van Itallie CM, Fanning AS, Bridges A, Anderson JM. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell. 2009;20:3930\u201340.","journal-title":"Mol Biol Cell"},{"key":"4091_CR23","doi-asserted-by":"publisher","first-page":"5653","DOI":"10.4049\/jimmunol.180.8.5653","volume":"180","author":"R Al-Sadi","year":"2008","unstructured":"Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol. 2008;180:5653\u201361.","journal-title":"J Immunol"},{"key":"4091_CR24","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1152\/ajpgi.00098.2016","volume":"311","author":"M Guerville","year":"2016","unstructured":"Guerville M, Boudry G. Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation. Am J Physiol Gastrointest Liver Physiol. 2016;311:G1\u201315.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4091_CR25","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3389\/fimmu.2017.01254","volume":"8","author":"C Da Silva","year":"2017","unstructured":"Da Silva C, Wagner C, Bonnardel J, Gorvel JP, Lelouard H. The peyer\u2019s patch mononuclear phagocyte system at steady state and during infection. Front Immunol. 2017;8:1254.","journal-title":"Front Immunol"},{"key":"4091_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/19490976.2017.1299846","volume":"8","author":"KA Knoop","year":"2017","unstructured":"Knoop KA, Gustafsson JK, McDonald KG, Kulkarni DH, Kassel R, Newberry RD. Antibiotics promote the sampling of luminal antigens and bacteria via colonic goblet cell associated antigen passages. Gut Microbes. 2017;8:400\u201311.","journal-title":"Gut Microbes"},{"issue":"Pt 4","key":"4091_CR27","first-page":"512","volume":"37","author":"SD Johnston","year":"2000","unstructured":"Johnston SD, Smye M, Watson RG, McMillan SA, Trimble ER, Love AH. Lactulose-mannitol intestinal permeability test: a useful screening test for adult coeliac disease. Ann Clin Biochem. 2000;37(Pt 4):512\u20139.","journal-title":"Ann Clin Biochem"},{"key":"4091_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12876-021-02082-z","volume":"22","author":"J Gan","year":"2022","unstructured":"Gan J, Nazarian S, Teare J, Darzi A, Ashrafian H, Thompson AJ. A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn\u2019s disease. BMC Gastroenterol. 2022;22:16.","journal-title":"BMC Gastroenterol"},{"issue":"388\u2013392","key":"4091_CR29","first-page":"392.e1","volume":"139","author":"H Neumann","year":"2010","unstructured":"Neumann H, Kiesslich R, Wallace MB, Neurath MF. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterol. 2010;139(388\u2013392):392.e1-2.","journal-title":"Gastroenterol"},{"key":"4091_CR30","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/0300060518820430","volume":"47","author":"L Sun","year":"2019","unstructured":"Sun L, Yue M, Dai Y, Yu C, Chen C. Confocal laser endomicroscopy reveals alterations in duodenal permeability in patients with acute pancreatitis. J Int Med Res. 2019;47:1279\u201387.","journal-title":"J Int Med Res"},{"key":"4091_CR31","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/ibd\/izz021","volume":"25","author":"AM Buchner","year":"2019","unstructured":"Buchner AM. Confocal laser endomicroscopy in the evaluation of inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:1302\u201312.","journal-title":"Inflamm Bowel Dis"},{"key":"4091_CR32","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/BF01296004","volume":"37","author":"T Kanda","year":"1992","unstructured":"Kanda T, Nakatomi Y, Ishikawa H, Hitomi M, Matsubara Y, Ono T, Muto T. Intestinal fatty acid-binding protein as a sensitive marker of intestinal ischemia. Dig Dis Sci. 1992;37:1362\u20137.","journal-title":"Dig Dis Sci"},{"key":"4091_CR33","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0140-6736(00)02169-3","volume":"355","author":"A Fasano","year":"2000","unstructured":"Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000;355:1518\u20139.","journal-title":"Lancet"},{"key":"4091_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.clnu.2008.02.005","volume":"27","author":"P Crenn","year":"2008","unstructured":"Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008;27:328\u201339.","journal-title":"Clin Nutr"},{"key":"4091_CR35","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1189\/jlb.3RU0316-151R","volume":"100","author":"RS Munford","year":"2016","unstructured":"Munford RS. Endotoxemia-menace, marker, or mistake? J Leukoc Biol. 2016;100:687\u201398.","journal-title":"J Leukoc Biol"},{"key":"4091_CR36","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0039-6060(03)00302-7","volume":"134","author":"LN Diebel","year":"2003","unstructured":"Diebel LN, Liberati DM, Dulchavsky SA, Diglio CA, Brown WJ. Enterocyte apoptosis and barrier function are modulated by SIgA after exposure to bacteria and hypoxia\/reoxygenation. Surgery. 2003;134:574\u201381.","journal-title":"Surgery"},{"key":"4091_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12967-019-1938-8","volume":"17","author":"D Dutta","year":"2019","unstructured":"Dutta D, Methe B, Amar S, Morris A, Lim SH. Intestinal injury and gut permeability in sickle cell disease. J Transl Med. 2019;17:183.","journal-title":"J Transl Med"},{"key":"4091_CR38","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/bjh.17889","volume":"196","author":"M Poplawska","year":"2022","unstructured":"Poplawska M, Dutta D, Jayaram M, Salifu M, Chong NS, Lim SH. Intestinal pathophysiological abnormalities in steady state and after vaso-occlusive crisis in murine sickle cell disease. Br J Haematol. 2022;196:777\u201380.","journal-title":"Br J Haematol"},{"key":"4091_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12967-018-1622-4","volume":"16","author":"SH Lim","year":"2018","unstructured":"Lim SH, Meth\u00e9 BA, Knoll BM, Morris A, Obaro SK. Invasive non-typhoidal Salmonella in sickle cell disease in Africa: is increased gut permeability the missing link? J Transl Med. 2018;16:239.","journal-title":"J Transl Med"},{"key":"4091_CR40","doi-asserted-by":"publisher","first-page":"e0255956","DOI":"10.1371\/journal.pone.0255956","volume":"16","author":"H Brim","year":"2021","unstructured":"Brim H, Taylor J, Abbas M, Vilmenay K, Daremipouran M, Varma S, Lee E, Pace B, Song-Naba WL, Gupta K, Nekhai S, O\u2019Neil P, Ashktorab H. The gut microbiome in sickle cell disease: characterization and potential implications. PLoS ONE. 2021;16:e0255956.","journal-title":"PLoS ONE"},{"key":"4091_CR41","doi-asserted-by":"publisher","first-page":"E91","DOI":"10.1002\/ajh.25019","volume":"93","author":"SH Lim","year":"2018","unstructured":"Lim SH, Morris A, Li K, Fitch AC, Fast L, Goldberg L, Quesenberry M, Sprinz P, Meth\u00e9 B. Intestinal microbiome analysis revealed dysbiosis in sickle cell disease. Am J Hematol. 2018;93:E91\u20133.","journal-title":"Am J Hematol"},{"key":"4091_CR42","doi-asserted-by":"publisher","first-page":"8659","DOI":"10.1038\/s41598-019-45270-4","volume":"9","author":"S Tavakoli","year":"2019","unstructured":"Tavakoli S, Xiao L. Depletion of intestinal microbiome partially rescues bone loss in sickle cell disease male mice. Sci Rep. 2019;9:8659.","journal-title":"Sci Rep"},{"key":"4091_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12967-021-03074-z","volume":"19","author":"T Jang","year":"2021","unstructured":"Jang T, Poplawska M, Cimpeanu E, Mo G, Dutta D, Lim SH. Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events. J Transl Med. 2021;19:397.","journal-title":"J Transl Med"},{"key":"4091_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1600-0609.1998.tb01036.x","volume":"60","author":"CC Anyaegbu","year":"1998","unstructured":"Anyaegbu CC, Okpala IE, Akren\u2019Ova YA, Salimonu LS. Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA). Eur J Haematol. 1998;60:267\u20138.","journal-title":"Eur J Haematol"},{"key":"4091_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/jlb.66.3.411","volume":"66","author":"LR Lard","year":"1999","unstructured":"Lard LR, Mul FP, de Haas M, Roos D, Duits AJ. Neutrophil activation in sickle cell disease. J Leukoc Biol. 1999;66:411\u20135.","journal-title":"J Leukoc Biol"},{"key":"4091_CR46","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/ajh.20059","volume":"76","author":"AF Lum","year":"2004","unstructured":"Lum AF, Wun T, Staunton D, Simon SI. Inflammatory potential of neutrophils detected in sickle cell disease. Am J Hematol. 2004;76:126\u201333.","journal-title":"Am J Hematol"},{"key":"4091_CR47","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","volume":"96","author":"JD Belcher","year":"2000","unstructured":"Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood. 2000;96:2451\u20139.","journal-title":"Blood"},{"key":"4091_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjh.12336","volume":"162","author":"E Sparkenbaugh","year":"2013","unstructured":"Sparkenbaugh E, Pawlinski R. Interplay between coagulation and vascular inflammation in sickle cell disease. Br J Haematol. 2013;162:3\u201314.","journal-title":"Br J Haematol"},{"key":"4091_CR49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature15367","volume":"525","author":"D Zhang","year":"2015","unstructured":"Zhang D, Chen G, Manwani D, Mortha A, Xu C, Faith JJ, Burk RD, Kunisaki Y, Jang JE, Scheiermann C, Merad M, Frenette PS. Neutrophil ageing is regulated by the microbiome. Nature. 2015;525:528\u201332.","journal-title":"Nature"},{"key":"4091_CR50","doi-asserted-by":"publisher","first-page":"27949","DOI":"10.1074\/jbc.M504049200","volume":"280","author":"M Wiens","year":"2005","unstructured":"Wiens M, Korzhev M, Krasko A, Thakur NL, Perovi\u0107-Ottstadt S, Breter HJ, Ushijima H, Diehl-Seifert B, M\u00fcller IM, M\u00fcller WE. Innate immune defense of the sponge Suberites domuncula against bacteria involves a MyD88-dependent signaling pathway. induction of a perforin-like molecule. J Biol Chem. 2005;280:27949\u201359.","journal-title":"J Biol Chem"},{"key":"4091_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/08830185.2016.1261318","volume":"36","author":"S Tartey","year":"2017","unstructured":"Tartey S, Takeuchi O. Pathogen recognition and toll-like receptor targeted therapeutics in innate immune cells. Int Rev Immunol. 2017;36:57\u201373.","journal-title":"Int Rev Immunol"},{"key":"4091_CR52","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/0300985814559404","volume":"52","author":"JM Williams","year":"2015","unstructured":"Williams JM, Duckworth CA, Burkitt MD, Watson AJ, Campbell BJ, Pritchard DM. Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Vet Pathol. 2015;52:445\u201355.","journal-title":"Vet Pathol"},{"key":"4091_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","volume":"2017","author":"AT Taher","year":"2017","unstructured":"Taher AT, Saliba AN. Iron overload in thalassemia: different organs at different rates. Hematology Am Soc Hematol Educ Program. 2017;2017:265\u201371.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"4091_CR54","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2147\/JIR.S273329","volume":"13","author":"K Sae-Khow","year":"2020","unstructured":"Sae-Khow K, Charoensappakit A, Visitchanakun P, Saisorn W, Svasti S, Fucharoen S, Leelahavanichkul A. Pathogen-associated molecules from gut translocation enhance severity of cecal ligation and puncture sepsis in iron-overload beta-Thalassemia mice. J Inflamm Res. 2020;13:719\u201335.","journal-title":"J Inflamm Res"},{"key":"4091_CR55","doi-asserted-by":"publisher","first-page":"G966","DOI":"10.1152\/ajpgi.00337.2019","volume":"318","author":"P Visitchanakun","year":"2020","unstructured":"Visitchanakun P, Saisorn W, Wongphoom J, Chatthanathon P, Somboonna N, Svasti S, Fucharoen S, Leelahavanichkul A. Gut leakage enhances sepsis susceptibility in iron-overloaded beta-thalassemia mice through macrophage hyperinflammatory responses. Am J Physiol Gastrointest Liver Physiol. 2020;318:G966\u201379.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4091_CR56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1473-3099(06)70437-6","volume":"6","author":"S Vento","year":"2006","unstructured":"Vento S, Cainelli F, Cesario F. Infections and thalassaemia. Lancet Infect Dis. 2006;6:226\u201333.","journal-title":"Lancet Infect Dis"},{"key":"4091_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijid.2015.09.001","volume":"39","author":"N Teawtrakul","year":"2015","unstructured":"Teawtrakul N, Jetsrisuparb A, Sirijerachai C, Chansung K, Wanitpongpun C. Severe bacterial infections in patients with non-transfusion-dependent thalassemia: prevalence and clinical risk factors. Int J Infect Dis. 2015;39:53\u20136.","journal-title":"Int J Infect Dis"},{"key":"4091_CR58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1196\/annals.1345.006","volume":"1054","author":"C Borgna-Pignatti","year":"2005","unstructured":"Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A, Romeo MA, Zhao H, Cnaan A. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40\u20137.","journal-title":"Ann N Y Acad Sci"},{"key":"4091_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jama.2019.19775","volume":"323","author":"AM Lerner","year":"2020","unstructured":"Lerner AM, Eisinger RW, Fauci AS. Comorbidities in persons with HIV: the lingering challenge. JAMA. 2020;323:19\u201320.","journal-title":"JAMA"},{"key":"4091_CR60","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365\u201371.","journal-title":"Nat Med"},{"key":"4091_CR61","doi-asserted-by":"publisher","first-page":"e1000852","DOI":"10.1371\/journal.ppat.1000852","volume":"6","author":"A Nazli","year":"2010","unstructured":"Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 2010;6:e1000852.","journal-title":"PLoS Pathog"},{"key":"4091_CR62","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrmicro2848","volume":"10","author":"NG Sandler","year":"2012","unstructured":"Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol. 2012;10:655\u201366.","journal-title":"Nat Rev Microbiol"},{"key":"4091_CR63","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3945\/ajcn.2009.27448","volume":"90","author":"P Crenn","year":"2009","unstructured":"Crenn P, De Truchis P, Neveux N, Galp\u00e9rine T, Cynober L, Melchior JC. Plasma citrulline is a biomarker of enterocyte mass and an indicator of parenteral nutrition in HIV-infected patients. Am J Clin Nutr. 2009;90:587\u201394.","journal-title":"Am J Clin Nutr"},{"key":"4091_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1172\/JCI59011","volume":"122","author":"M Mavigner","year":"2012","unstructured":"Mavigner M, Cazabat M, Dubois M, L\u2019Faqihi FE, Requena M, Pasquier C, Klopp P, Amar J, Alric L, Barange K, Vinel JP, Marchou B, Massip P, Izopet J, Delobel P. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest. 2012;122:62\u20139.","journal-title":"J Clin Invest"},{"key":"4091_CR65","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/cid\/ciz212","volume":"70","author":"V Mehraj","year":"2020","unstructured":"Mehraj V, Ramendra R, Isnard S, Dupuy FP, Ponte R, Chen J, Kema I, Jenabian MA, Costinuik CT, Lebouch\u00e9 B, Thomas R, Cot\u00e9 P, Leblanc R, Baril JG, Durand M, Chartrand-Lefebvre C, Tremblay C, Ancuta P, Bernard NF, Sheppard DC, Routy JP. Montreal primary HIV infection study and canadian HIV and aging cohort study groups. circulating (1\u2013>3)-beta-D-glucan is associated with immune activation during human immunodeficiency virus infection. Clin Infect Dis. 2020;70:232\u201341.","journal-title":"Clin Infect Dis"},{"key":"4091_CR66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CMR.00050-12","volume":"26","author":"G Marchetti","year":"2013","unstructured":"Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev. 2013;26:2\u201318.","journal-title":"Clin Microbiol Rev"},{"key":"4091_CR67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(14)70917-X","volume":"15","author":"MA Huson","year":"2015","unstructured":"Huson MA, Grobusch MP, van der Poll T. The effect of HIV infection on the host response to bacterial sepsis. Lancet Infect Dis. 2015;15:95\u2013108.","journal-title":"Lancet Infect Dis"},{"key":"4091_CR68","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/infdis\/jiy727","volume":"219","author":"SJ Leopold","year":"2019","unstructured":"Leopold SJ, Ghose A, Allman EL, Kingston HWF, Hossain A, Dutta AK, Plewes K, Chotivanich K, Day NPJ, Tarning J, Winterberg M, White NJ, Llin\u00e1s M, Dondorp AM. Identifying the components of acidosis in patients with severe Plasmodium falciparum malaria using metabolomics. J Infect Dis. 2019;219:1766\u201376.","journal-title":"J Infect Dis"},{"key":"4091_CR69","first-page":"100036","volume":"2","author":"E Donnelly","year":"2021","unstructured":"Donnelly E, de Water JV, Luckhart S. Malaria-induced bacteremia as a consequence of multiple parasite survival strategies. Curr Res Microb Sci. 2021;2:100036.","journal-title":"Curr Res Microb Sci"},{"key":"4091_CR70","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00726-014-1773-4","volume":"47","author":"B Wang","year":"2015","unstructured":"Wang B, Wu G, Zhou Z, Dai Z, Sun Y, Ji Y, Li W, Wang W, Liu C, Han F, Wu Z. Glutamine and intestinal barrier function. Amino Acids. 2015;47:2143\u201354.","journal-title":"Amino Acids"},{"key":"4091_CR71","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ijpara.2014.03.002","volume":"44","author":"HM Abkallo","year":"2014","unstructured":"Abkallo HM, Liu W, Hokama S, Ferreira PE, Nakazawa S, Maeno Y, Quang NT, Kobayashi N, Kaneko O, Huffman MA, Kawai S, Marchand RP, Carter R, Hahn BH, Culleton R. DNA from pre-erythrocytic stage malaria parasites is detectable by PCR in the faeces and blood of hosts. Int J Parasitol. 2014;44:467\u201373.","journal-title":"Int J Parasitol"},{"key":"4091_CR72","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2165\/00002512-199507030-00006","volume":"7","author":"SM Lichtman","year":"1995","unstructured":"Lichtman SM. Physiological aspects of aging implications for the treatment of cancer. Drugs Aging. 1995;7:212\u201325.","journal-title":"Drugs Aging"},{"key":"4091_CR73","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00280-016-3150-3","volume":"78","author":"RA Forsg\u00e5rd","year":"2016","unstructured":"Forsg\u00e5rd RA, Korpela R, Holma R, Lind\u00e9n J, Frias R, Spillmann T, \u00d6sterlund P. Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in sprague-dawley rats. Cancer Chemother Pharmacol. 2016;78:863\u201374.","journal-title":"Cancer Chemother Pharmacol"},{"key":"4091_CR74","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4161\/cbt.27222","volume":"15","author":"HR Wardill","year":"2014","unstructured":"Wardill HR, Bowen JM, Al-Dasooqi N, Sultani M, Bateman E, Stansborough R, Shirren J, Gibson RJ. Irinotecan disrupts tight junction proteins within the gut: implications for chemotherapy-induced gut toxicity. Cancer Biol Ther. 2014;15:236\u201344.","journal-title":"Cancer Biol Ther"},{"key":"4091_CR75","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/MPG.0b013e318247240d","volume":"54","author":"S Beutheu Youmba","year":"2012","unstructured":"Beutheu Youmba S, Belmonte L, Galas L, Boukhettala N, B\u00f4le-Feysot C, D\u00e9chelotte P, Co\u00ebffier M. Methotrexate modulates tight junctions through NF-\u03baB, MEK, and JNK pathways. J Pediatr Gastroenterol Nutr. 2012;54:463\u201370.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4091_CR76","doi-asserted-by":"publisher","first-page":"G367","DOI":"10.1152\/ajpgi.00173.2003","volume":"286","author":"TY Ma","year":"2004","unstructured":"Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM. TNF-\u03b1-induced increase in intestinal epithelial tight junction permeability requires NF-\u03baB activation. Am J Physiol-Gastrointest Liver Physiol. 2004;286:G367\u201376.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"4091_CR77","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ctrv.2007.03.001","volume":"33","author":"RM Logan","year":"2007","unstructured":"Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev. 2007;33:448\u201360.","journal-title":"Cancer Treat Rev"},{"key":"4091_CR78","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.4161\/cbt.7.7.6207","volume":"7","author":"RM Logan","year":"2008","unstructured":"Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther. 2008;7:1139\u201345.","journal-title":"Cancer Biol Ther"},{"key":"4091_CR79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/oxfordjournals.jncimonographs.a003435","volume":"2001","author":"DA Williams","year":"2001","unstructured":"Williams DA. Inflammatory cytokines and mucosal injury. JNCI Monogr. 2001;2001:26\u201330.","journal-title":"JNCI Monogr"},{"key":"4091_CR80","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0022-4804(03)00311-1","volume":"116","author":"LS Poritz","year":"2004","unstructured":"Poritz LS, Garver KI, Tilberg AF, Koltun WA. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res. 2004;116:14\u20138.","journal-title":"J Surg Res"},{"key":"4091_CR81","doi-asserted-by":"publisher","first-page":"G422","DOI":"10.1152\/ajpgi.00412.2004","volume":"288","author":"TY Ma","year":"2005","unstructured":"Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-\u03b1 modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol-Gastrointest Liver Physiol. 2005;288:G422-430.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"4091_CR82","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1177\/154411130201300502","volume":"13","author":"ST Sonis","year":"2002","unstructured":"Sonis ST. The biologic role for nuclear factor-kappa B in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med. 2002;13:380\u20139.","journal-title":"Crit Rev Oral Biol Med"},{"key":"4091_CR83","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0039-6060(96)80317-5","volume":"120","author":"BC Marcus","year":"1996","unstructured":"Marcus BC, Wyble CW, Hynes KL, Gewertz BL. Cytokine-induced increases in endothelial permeability occur after adhesion molecule expression. Surgery. 1996;120:411\u20137.","journal-title":"Surgery"},{"key":"4091_CR84","first-page":"231","volume":"4","author":"AP Singh","year":"2015","unstructured":"Singh AP, Aijaz S. Enteropathogenic E. coli: breaking the intestinal tight junction barrier. Res. 2015;4:231.","journal-title":"Res"},{"key":"4091_CR85","doi-asserted-by":"publisher","first-page":"e2024651118","DOI":"10.1073\/pnas.2024651118","volume":"118","author":"AJ Vecchio","year":"2021","unstructured":"Vecchio AJ, Rathnayake SS, Stroud RM. Structural basis for Clostridium perfringens enterotoxin targeting of claudins at tight junctions in mammalian gut. Proc Natl Acad Sci USA. 2021;118:e2024651118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4091_CR86","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.3390\/ijms22179474","volume":"22","author":"L Wei","year":"2021","unstructured":"Wei L, Wen XS, Xian CJ. Chemotherapy-induced intestinal microbiota dysbiosis impairs mucosal homeostasis by modulating toll-like receptor signaling pathways. Int J Mol Sci. 2021;22:9474.","journal-title":"Int J Mol Sci"},{"key":"4091_CR87","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","volume":"42","author":"E Montassier","year":"2015","unstructured":"Montassier E, Gastinne T, Vangay P, Al-Ghalith GA, des Bruley Varannes S, Massart S, Moreau P, Potel G, de La Cocheti\u00e8re MF, Batard E, Knights D. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42:515\u201328.","journal-title":"Aliment Pharmacol Ther"},{"key":"4091_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19:29\u201341.","journal-title":"Environ Microbiol"},{"key":"4091_CR89","doi-asserted-by":"publisher","first-page":"6259381","DOI":"10.1155\/2021\/6259381","volume":"2021","author":"Q Sun","year":"2021","unstructured":"Sun Q, Ji YC, Wang ZL, She X, He Y, Ai Q, Li LQ. Sodium butyrate alleviates intestinal inflammation in mice with necrotizing enterocolitis. Mediators Inflamm. 2021;2021:6259381.","journal-title":"Mediators Inflamm"},{"key":"4091_CR90","doi-asserted-by":"publisher","first-page":"e0179586","DOI":"10.1371\/journal.pone.0179586","volume":"12","author":"H Yan","year":"2017","unstructured":"Yan H, Ajuwon KM. Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. PLoS ONE. 2017;12:e0179586.","journal-title":"PLoS ONE"},{"key":"4091_CR91","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.2174\/1381612824666181001153605","volume":"24","author":"JPB Silva","year":"2018","unstructured":"Silva JPB, Navegantes-Lima KC, Oliveira ALB, Rodrigues DVS, Gaspar SLF, Monteiro VVS, Moura DP, Monteiro MC. Protective mechanisms of butyrate on inflammatory bowel disease. Curr Pharm Des. 2018;24:4154\u201366.","journal-title":"Curr Pharm Des"},{"key":"4091_CR92","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1128\/CMR.18.2.247-263.2005","volume":"18","author":"DE Voth","year":"2005","unstructured":"Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005;18:247\u201363.","journal-title":"Clin Microbiol Rev"},{"key":"4091_CR93","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1469-0691.2011.03571.x","volume":"18","author":"SM McGlone","year":"2012","unstructured":"McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, Muder RR, Lee BY. The economic burden of clostridium difficile. Clin Microbiol Infect. 2012;18:282\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"4091_CR94","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.bbmt.2012.02.010","volume":"18","author":"L Willems","year":"2012","unstructured":"Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, Andreoli AL, Rodriguez-Otero P, Dhedin N, Soci\u00e9 G, Ribaud P, de Peffault Latour R. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transplant. 2012;18:1295\u2013301.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4091_CR95","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.bbmt.2014.06.025","volume":"20","author":"M Kamboj","year":"2014","unstructured":"Kamboj M, Xiao K, Kaltsas A, Huang YT, Sun J, Chung D, Wu S, Sheahan A, Sepkowitz K, Jakubowski AA, Papanicolaou G. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1\/027. Biol Blood Marrow Transplant. 2014;20:1626\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4091_CR96","doi-asserted-by":"publisher","first-page":"e1006202","DOI":"10.1371\/journal.ppat.1006202","volume":"13","author":"E Maidji","year":"2017","unstructured":"Maidji E, Somsouk M, Rivera JM, Hunt PW, Stoddart CA. Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction. PLoS Pathog. 2017;13:e1006202.","journal-title":"PLoS Pathog"},{"key":"4091_CR97","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000331587","volume":"21","author":"E Alt\u0131nel","year":"2012","unstructured":"Alt\u0131nel E, Yarali N, Is\u0131k P, Bay A, Kara A, Tunc B. Typhlitis in acute childhood leukemia. Med Princ Pract. 2012;21:36\u20139.","journal-title":"Med Princ Pract"},{"key":"4091_CR98","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41417-021-00418-1","volume":"29","author":"M Sheykhhasan","year":"2022","unstructured":"Sheykhhasan M, Manoochehri H, Dama P. Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study. Cancer Gene Ther. 2022;29:1080\u201396.","journal-title":"Cancer Gene Ther"},{"key":"4091_CR99","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.beha.2018.04.001","volume":"31","author":"JC Chavez","year":"2018","unstructured":"Chavez JC, Locke FL. CAR T cell therapy for B-cell lymphomas. Best Pract Res Clin Haematol. 2018;31:135\u201346.","journal-title":"Best Pract Res Clin Haematol"},{"key":"4091_CR100","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/BLCTT.S327016","volume":"12","author":"MJ Rendo","year":"2022","unstructured":"Rendo MJ, Joseph JJ, Phan LM, DeStefano CB. CAR T-cell therapy for patients with multiple myeloma: current evidence and challenges. Blood Lymphat Cancer. 2022;12:119\u201336.","journal-title":"Blood Lymphat Cancer"},{"key":"4091_CR101","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/MOH.0b013e32833eaf1b","volume":"17","author":"L Luznik","year":"2010","unstructured":"Luznik L, Jones RJ, Fuchs EJ. High-dose cyclophosphamide for graft-versus-host disease prevention. Curr Opin Hematol. 2010;17:493\u20139.","journal-title":"Curr Opin Hematol"},{"key":"4091_CR102","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10096-016-2881-8","volume":"36","author":"R Gao","year":"2017","unstructured":"Gao R, Gao Z, Huang L, Qin H. Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis. 2017;36:757\u201369.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4091_CR103","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4251\/wjgo.v10.i3.71","volume":"10","author":"FM Shang","year":"2018","unstructured":"Shang FM, Liu HL. Fusobacterium nucleatum and colorectal cancer: a review. World J Gastrointest Oncol. 2018;10:71\u201381.","journal-title":"World J Gastrointest Oncol"},{"key":"4091_CR104","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000494052","volume":"100","author":"C Lin","year":"2019","unstructured":"Lin C, Cai X, Zhang J, Wang W, Sheng Q, Hua H, Zhou X. Role of gut microbiota in the development and treatment of colorectal cancer. Digestion. 2019;100:72\u20138.","journal-title":"Digestion"},{"key":"4091_CR105","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature11465","volume":"491","author":"SI Grivennikov","year":"2012","unstructured":"Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M. Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth. Nature. 2012;491:254\u20138.","journal-title":"Nature"},{"key":"4091_CR106","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1126\/science.1069094","volume":"295","author":"A Velcich","year":"2002","unstructured":"Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K, Augenlicht L. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002;295:1726\u20139.","journal-title":"Science"},{"key":"4091_CR107","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1038\/onc.2011.545","volume":"31","author":"P Kosa","year":"2012","unstructured":"Kosa P, Szabo R, Molinolo AA, Bugge TH. Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis. Oncogene. 2012;31:3679\u201395.","journal-title":"Oncogene"},{"key":"4091_CR108","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1073\/pnas.0903923107","volume":"107","author":"MS Buzza","year":"2010","unstructured":"Buzza MS, Netzel-Arnett S, Shea-Donohue T, Zhao A, Lin CY, List K, Szabo R, Fasano A, Bugge TH, Antalis TM. Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci USA. 2010;107:4200\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4091_CR109","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","volume":"557","author":"M Meisel","year":"2018","unstructured":"Meisel M, Hinterleitner R, Pacis A, Chen L, Earley ZM, Mayassi T, Pierre JF, Ernest JD, Galipeau HJ, Thuille N, Bouziat R, Buscarlet M, Ringus DL, Wang Y, Li Y, Dinh V, Kim SM, McDonald BD, Zurenski MA, Musch MW, Furtado GC, Lira SA, Baier G, Chang EB, Eren AM, Weber CR, Busque L, Godley LA, Verd\u00fa EF, Barreiro LB, Jabri B. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature. 2018;557:580\u20134.","journal-title":"Nature"},{"key":"4091_CR110","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1038\/s41467-022-30240-8","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang R, Yang X, Liu J, Zhong F, Zhang C, Chen Y, Sun T, Ji C, Ma D. Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun. 2022;13:2522.","journal-title":"Nat Commun"},{"key":"4091_CR111","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1172\/JCI98554","volume":"129","author":"SC Nalle","year":"2019","unstructured":"Nalle SC, Zuo L, Ong MLDM, Singh G, Worthylake AM, Choi W, Manresa MC, Southworth AP, Edelblum KL, Baker GJ, Joseph NE, Savage PA, Turner JR. Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability. J Clin Invest. 2019;129:902\u201314.","journal-title":"J Clin Invest"},{"key":"4091_CR112","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.3390\/jcm10112508","volume":"10","author":"M Tyszka","year":"2021","unstructured":"Tyszka M, Bili\u0144ski J, Basak GW. Advances in intestinal barrier preservation and restoration in the allogeneic hematopoietic cell transplantation setting. J Clin Med. 2021;10:2508.","journal-title":"J Clin Med"},{"key":"4091_CR113","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, da Burgos Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Y\u00e1\u00f1ez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med. 2020;382:822\u201334.","journal-title":"N Engl J Med"},{"key":"4091_CR114","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1007\/s10620-006-9404-x","volume":"52","author":"JE Johansson","year":"2007","unstructured":"Johansson JE, Ekman T. Gut toxicity during hemopoietic stem cell transplantation may predict acute graft-versus-host disease severity in patients. Dig Dis Sci. 2007;52:2340\u20135.","journal-title":"Dig Dis Sci"},{"key":"4091_CR115","doi-asserted-by":"publisher","first-page":"1968257","DOI":"10.1080\/19490976.2021.1968257","volume":"13","author":"G Li","year":"2021","unstructured":"Li G, Lin J, Zhang C, Gao H, Lu H, Gao X, Zhu R, Li Z, Li M, Liu Z. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. Gut Microbes. 2021;13:1968257.","journal-title":"Gut Microbes"},{"key":"4091_CR116","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jpeds.2004.06.068","volume":"145","author":"V Rosenfeldt","year":"2004","unstructured":"Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr. 2004;145:612\u20136.","journal-title":"J Pediatr"},{"key":"4091_CR117","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1053\/gast.2001.27224","volume":"121","author":"K Madsen","year":"2001","unstructured":"Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterol. 2001;121:580\u201391.","journal-title":"Gastroenterol"},{"key":"4091_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medmal.2013.10.002","volume":"44","author":"MJ Butel","year":"2014","unstructured":"Butel MJ. Probiotics, gut microbiota and health. Med Mal Infect. 2014;44:1\u20138.","journal-title":"Med Mal Infect"},{"key":"4091_CR119","first-page":"892971","volume":"2011","author":"A de de Moreno Leblanc","year":"2011","unstructured":"de de Moreno Leblanc A, Del Carmen S, Zurita-Turk M, Santos Rocha C, de Guchte M, Azevedo V, Miyoshi A, Leblanc JG. Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases. ISRN Gastroenterol. 2011;2011:892971.","journal-title":"ISRN Gastroenterol"},{"key":"4091_CR120","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3201\/eid2708.210018","volume":"27","author":"J Rannikko","year":"2021","unstructured":"Rannikko J, Holmberg V, Karppelin M, Arvola P, Huttunen R, Mattila E, Kerttula N, Puhto T, Tamm \u00dc, Koivula I, Vuento R, Syrj\u00e4nen J, Hohenthal U. Fungemia and other fungal infections associated with use of Saccharomyces boulardii probiotic supplements. Emerg Infect Dis. 2021;27:2090\u20136.","journal-title":"Emerg Infect Dis"},{"key":"4091_CR121","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/bmt.2015.275","volume":"51","author":"EJ Ladas","year":"2016","unstructured":"Ladas EJ, Bhatia M, Chen L. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplant. 2016;51:262\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"4091_CR122","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/1756283X12453637","volume":"5","author":"F Rohlke","year":"2012","unstructured":"Rohlke F, Stollman N. Fecal microbiota transplantation in relapsing clostridium difficile infection. Therap Adv Gastroenterol. 2012;5:403\u201320.","journal-title":"Therap Adv Gastroenterol"},{"key":"4091_CR123","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/cancers14030691","volume":"14","author":"M Bou Zerdan","year":"2022","unstructured":"Bou Zerdan M, Niforatos S, Nasr S, Nasr D, Ombada M, John S, Dutta D, Lim SH. Fecal microbiota transplant for hematologic and oncologic diseases: principle and practice. Cancers. 2022;14:691.","journal-title":"Cancers"},{"key":"4091_CR124","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH, Turbett S, Chung RT, Chen YB, Hohmann EL. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med. 2019;381:2043\u201350.","journal-title":"N Engl J Med"},{"key":"4091_CR125","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, de Barsy M, Loumaye A, Hermans MP, Thissen JP, de Vos WM, Cani PD. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25:1096\u2013103.","journal-title":"Nat Med"},{"key":"4091_CR126","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1158\/0008-5472.CAN-18-3464","volume":"79","author":"CB Rosean","year":"2019","unstructured":"Rosean CB, Bostic RR, Ferey JC, Feng T, Azar FN, Tung KS, Dozmorov MG, Smirnova E, Bos PD, Rutkowski MR. Preexisting commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor\u2013positive breast cancer. Cancer Res. 2019;79:3662\u201375.","journal-title":"Cancer Res"},{"key":"4091_CR127","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","volume":"167","author":"MS Desai","year":"2016","unstructured":"Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167:1339-1353.e21.","journal-title":"Cell"},{"key":"4091_CR128","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/ijms18051051","volume":"18","author":"MH Kim","year":"2017","unstructured":"Kim MH, Kim H. The Roles of glutamine in the intestine and its implication in intestinal diseases. Int J Mol Sci. 2017;18:1051.","journal-title":"Int J Mol Sci"},{"key":"4091_CR129","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1715971","volume":"379","author":"Y Niihara","year":"2018","unstructured":"Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP. Investigators of the phase 3 trial of L-glutamine in sickle cell disease. a phase 3 trial of L-glutamine in sickle cell disease. N Engl J Med. 2018;379:226\u201335.","journal-title":"N Engl J Med"},{"key":"4091_CR130","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/1534735418794885","volume":"17","author":"M Thomsen","year":"2018","unstructured":"Thomsen M, Vitetta L. Adjunctive treatments for the prevention of chemotherapy- and radiotherapy-induced mucositis. Integr Cancer Ther. 2018;17:1027\u201347.","journal-title":"Integr Cancer Ther"},{"key":"4091_CR131","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/0884533615611857","volume":"31","author":"C Sayles","year":"2016","unstructured":"Sayles C, Hickerson SC, Bhat RR, Hall J, Garey KW, Trivedi MV. Oral glutamine in preventing treatment-related mucositis in adult patients with cancer: a systematic review. Nutr Clin Pract. 2016;31:171\u20139.","journal-title":"Nutr Clin Pract"},{"key":"4091_CR132","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/14712590902976837","volume":"9","author":"U Athar","year":"2009","unstructured":"Athar U, Gentile TC. Keratinocyte growth factor. Expert Opin Biol Ther. 2009;9:779\u201387.","journal-title":"Expert Opin Biol Ther"},{"key":"4091_CR133","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00535-005-1705-x","volume":"40","author":"A Ido","year":"2005","unstructured":"Ido A, Numata M, Kodama M, Tsubouchi H. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J Gastroenterol. 2005;40:925\u201331.","journal-title":"J Gastroenterol"},{"key":"4091_CR134","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1532-950X.2000.00017.x","volume":"29","author":"WF Johnson","year":"2000","unstructured":"Johnson WF, DiPalma CR, Ziegler TR, Scully S, Farrell CL. Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome. Vet Surg. 2000;29:17\u201327.","journal-title":"Vet Surg"},{"key":"4091_CR135","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/0148607103027003198","volume":"27","author":"H Yang","year":"2003","unstructured":"Yang H, Wildhaber BE, Teitelbaum DH. Keratinocyte growth factor improves epithelial function after massive small bowel resection. JPEN J Parenter Enteral Nutr. 2003;27:198\u2013206.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"4091_CR136","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/bmt.2008.168","volume":"42","author":"P Tsirigotis","year":"2008","unstructured":"Tsirigotis P, Triantafyllou K, Girkas K, Giannopoulou V, Ioannidou E, Chondropoulos S, Kalli T, Papaxoinis G, Pappa V, Papageorgiou E, Economopoulos T, Ladas SD, Dervenoulas J. Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study. Bone Marrow Transplant. 2008;42:337\u201343.","journal-title":"Bone Marrow Transplant"},{"key":"4091_CR137","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"SC Bischoff","year":"2014","unstructured":"Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM. Intestinal permeability\u2013a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.","journal-title":"BMC Gastroenterol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04091-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04091-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04091-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T11:06:32Z","timestamp":1680260792000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04091-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4091"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04091-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}